World Lung Cancer Day: Key Insights and Advances in Lung Cancer Trea…

Oncology Data Advisor

S. Kareff, B. Sandy, M. Vojnic

ASCO® 2024 Review: Treatment Updates on Unresectable Malignant Pleur…

Nebraska Oncology Society

V. Lam

ASCO® 2024 Insights: "First-in-Human Trial of RSO-021 in Malignant P…

2024 ASCO® Annual Meeting Insights Hub

D. Fennell

Value of NGS in Solid Tumors

Michelle Shiller

First-in-Class, First-in-Human Phase 1 Trial of VT3989, an Inhibitor…

AACR 2023 Conference Coverage

T. Yap

Emerging Biomarkers for Mesothelioma: Prognostic/Predictive Biomarke…

Oluf Dimitri Røe

An Exhaled Breath Biopsy Earmarks Exclusive Screening for Malignant …

Kevin Lamote

The Role of Decortication in Mesothelioma

Raja Flores

Lung Cancer Screening and Approach to the Lung Nodule

Brigham and Women's Hospital

A. Ramaswamy

Lung Cancer Screening

Kyle Hogarth

WCLC 2024 Insights: Optimal Management of Malignant Pleural Effusion

Insights from 2024 WCLC

P. Lee

ESMO 2024 Insights: Treatment Rechallenge After Grade 1 Trastuzumab-…

2024 ESMO Annual Meeting Insights Hub

K. Natsuhara

The Use of IO Doublet in PD-L1-Negative NSCLC

David Carbone

Metaphorical Signs in Computed Tomography of Chest

Atul C. Mehta

Metastatic EGFRm NSCLC: 1L Therapy Options

University of Colorado Cancer Center

T. Patil

ESMO 2024 Summary: Management of Oligoprogressive Disease - Patients…

2024 ESMO Annual Meeting Insights Hub

R. Van den Begin

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

AdventHealth

G. Sonpavde

Lazertinib in 1L EGFR-Mutant NSCLC: Unique Mechanism and Benefits of…

Mariam Alexander

Year in Review 2024 - NSCLC Perioperative Therapy

Oncology 2024 Year in Review

B. Halmos

Year in Review 2024 - Transformative FDA Approvals in Precision Onco…

Oncology 2024 Year in Review

V. Subbiah